Search
Protagonist Therapeutics Inc
PTGXAdd to Watchlist
136.640USD
-2.000-1.44%
Close 07-31 16:00（ET）Quotes delayed by 15 min
8.55BMarket Cap
LossP/E TTM
Protagonist Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Protagonist Therapeutics Inc is 4.19, ranking 370 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -75.74, which is -262.10% below the recent high of 122.78 and -3.12% above the recent low of -78.11.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.